Amphastar Pharmaceuticals Financial Overview
Amphastar Pharmaceuticals's market cap is currently $1.18B. The company's EPS TTM is $0.93; its P/E ratio is 11.48; Amphastar Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.93. See an overview of income statement, balance sheet, and cash flow financials.
